Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Apr 2009

von Wyl Viktor, Yerly Sabine, Bürgisser Philippe, Klimkait Thomas, Battegay Manuel, Bernasconi Enos, Cavassini Matthias, Furrer Hansjakob, Hirschel Bernard, Vernazza Pietro L, Francioli Patrick, Bonhoeffer Sebastian, Ledergerber Bruno, Günthard Huldrych F

Abstract excerpt

BACKGROUND: Accurate quantification of the prevalence of human immunodeficiency virus type 1 (HIV-1) drug resistance in patients who are receiving antiretroviral therapy (ART) is difficult, and results from previous studies vary. We attempted to assess the prevalence and dynamics of resistance in a highly representative patient cohort from Switzerland. METHODS: On the basis of genotypic resistance test results...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to HIV Infections

Share to Prevalence

Share to Switzerland

Share to Young Adult

Source

Identifiers

PMID: 19228107
DOI: 10.1086/597352

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland.PMID 19228107Read ↗

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.Semantic proximity Read ↗

Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe.Semantic proximity Read ↗

Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.Semantic proximity Read ↗

Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1.Semantic proximity Read ↗

Prevalence of HIV-1 Drug Resistance in Treated PatientsSemantic proximity Read ↗

Epidemiology of transmitted drug resistance in chronically HIV-infected patients in Germany: the RESINA study 2001-2009.Semantic proximity Read ↗

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.Semantic proximity Read ↗

Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infection.Semantic proximity Read ↗

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.Semantic proximity Read ↗

Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.Semantic proximity Read ↗

Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in Germany.Semantic proximity Read ↗

Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.